Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF), and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.
Company profile
Ticker
IGATY
Exchange
Website
CEO
Meenu Chhabra Karson
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Voya Financial • AbbVie • BankUnited • News • Evergy • Zoetis • Amdocs Limited • Sensata Technologies Holding • BJ's Wholesale Club • Kosmos Energy ...
Former names
Patni Computer Systems LTD
SEC CIK
Corporate docs
Latest filings (excl ownership)
SC TO-T/A
Third party tender offer statement (amended)
30 May 13
SC 13E3/A
Going private transaction (amended)
28 May 13
SC TO-T/A
Third party tender offer statement (amended)
12 Feb 13
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
11 Jan 13
SC TO-T/A
Third party tender offer statement (amended)
3 Jan 13
CORRESP
Correspondence with SEC
16 Oct 12
UPLOAD
Letter from SEC
10 Oct 12
15-12B
Securities registration termination
1 Oct 12
25
Voluntary exchange delisting
18 Sep 12
6-K
Current report (foreign)
18 Sep 12
Latest ownership filings
SC 13D/A
ELLIOTT ASSOCIATES, L.P.
20 Apr 12
SC 13D/A
ELLIOTT ASSOCIATES, L.P.
20 Mar 12
SC 13D/A
ELLIOTT ASSOCIATES, L.P.
15 Feb 12
SC 13D/A
ELLIOTT ASSOCIATES, L.P.
2 Dec 11
SC 13D/A
IGATE CORP
22 Nov 11
SC 13D/A
ELLIOTT ASSOCIATES, L.P.
21 Nov 11
SC 13D/A
ELLIOTT ASSOCIATES, L.P.
17 Nov 11
SC 13D
ELLIOTT ASSOCIATES, L.P.
26 Oct 11
SC 13D
IGATE CORP
20 May 11
SC 13D/A
GENERAL ATLANTIC LLC
13 May 11